Upload Image (Max 20MB per Image)
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug ...
Tags: NPS Pharmaceuticals, European Commission, Natpara®